The role of T790M mutation in EGFR-TKI re-challenge for patients with EGFR-mutant advanced lung adenocarcinoma

Similar Items

• Effects of epidermal growth factor receptor‐tyrosine kinase inhibitors alone on EGFR‐mutant non‐small cell lung cancer with brain metastasis
  od: Zhang, Qiuyi, i dr.
  Izdano: (2016)
• Plasma T790M and HGF as potential predictive markers for EGFR-TKI re-challenge
  od: Nakamura, Tomomi, i dr.
  Izdano: (2017)
• The emergence of T790M mutation in EGFR-mutant lung adenocarcinoma patients having a history of acquired resistance to EGFR-TKI: focus on rebiopsy timing and long-term existence of T790M
  od: Tseng, Jeng-Sen, i dr.
  Izdano: (2016)
• Overcoming T790M mutant small cell lung cancer with the third‐generation EGFR‐TKI osimertinib
  od: Kejing Tang, i dr.
  Izdano: (2019-02-01)
• Overcoming T790M mutant small cell lung cancer with the third‐generation EGFR‐TKI osimertinib
  od: Tang, Kejing, i dr.
  Izdano: (2018)